Clinical trials involve more than appointments. Clear instructions, follow-ups, and accessible communication matter, too. Could AI voice agents help? The real measure is whether they improve the participant experience while protecting privacy and trust. #AlzheimersResearch

Could AI voice agents make clinical research more accessible? 🤖 From routine follow-ups to patient communication, the possibilities are worth exploring—but safety, privacy, and trust must come first. Join Dr. Michael Weiner Oct. 27: na2.hubs.ly/H08rNZl0 #AlzheimersDisease

🏆 The Peter Cohen Foundation, operating as EverythingALS + EverythingALZ, has been nominated for the inaugural Prix Galien Patient First Award. The nomination recognizes the EverythingALS Citizen-Driven Research & Innovation Platform. #PrixGalien #PatientFirst #EverythingALZ

A new name and a new online home 💜 EverythingAD is now EverythingALZ! Follow our new Facebook Page and visit 🌐 na2.hubs.ly/H08nwdg0 to stay connected. #AlzheimersDisease #Alzheimers #dementia #caretocure #EverythingALZ

🔴 TODAY! Join EverythingALZ + Dr. David Soleimani-Meigooni: 🧠 Alzheimer’s Disease Testing & Precision Medicine ⏰2 PM PT/5 PM ET 🌐 tinyurl.com/ETOct13 Bring questions! #Alzheimers #ExpertTalk #CaretoCure #PreisionMedicine #AlzheimersResearch #dementia #BrainHealth

⏰ TOMORROW! Join EverythingALZ + Dr. David Soleimani-Meigooni: 🧠 Alzheimer’s Disease Testing & Precision Medicine ⏰2 PM PT/5 PM ET 🌐 tinyurl.com/ETOct13 #Alzheimers #ExpertTalk #caretocure #AlzheimersDisease #PrecisionMedicine #EverythingALZ

If you're concerned about changes in memory or thinking, start with questions: What could be causing this? What testing might help? Could another condition or medication contribute? You don't need all the answers before seeking help. 🧠 #Alzheimers #CareToCure #EverythingALZ

Could Alzheimer’s testing help make care more personal? Join Dr. David Soleimani-Meigooni, MD, for an EverythingALZ Expert Talk on testing and precision medicine. 📆Oct. 13 | 2 pm PT / 4 pm CT / 5 pm ET Register: tinyurl.com/ETOct13 #AlzheimersDisease #caretocure

Science doesn't have to be oversimplified to be understandable. Patients and caregivers deserve clear information, honest uncertainty and the opportunity to ask better questions. 🧠❤️ #Alzheimers #CareToCure #AlzheimersDisease #dementia #EverythingALZ

Not every forgotten name or misplaced phone is Alzheimer’s. Occasional forgetfulness can be part of normal aging. Persistent changes that interfere with everyday life deserve a conversation with a healthcare professional. 🧠 #AlzheimersDisease #caretocure #Alzheimers #dementia

🎯 Precision medicine asks an important question: Can better information about an individual make Alzheimer’s care more precise? That question is shaping today's research. #Alzheimers #PrecisionMedicine #AlzheimersDisease #dementia #caretocure #AlzheimersResearch

🩸 Alzheimer’s blood tests are advancing rapidly. But "promising" doesn't mean "perfect." Different tests can vary in accuracy and use. Context matters. 🧠 #Alzheimers #Biomarkers #caretocure #brainhealth #AlzheimersDisease #AlzheimersResearch

Our next Expert Talk will feature David Soleimani-Meigooni, MD, Assistant Professor of Neurology at UCSF. We'll explore advancements in testing and precision medicine and their impact on #Alzheimers care. 📅 October 13, 2026 ⏰ 2 PM PT / 5 PM ET 🌐 tinyurl.com/ETOct13

🧪 What is an Alzheimer’s biomarker? It's a measurable sign of biological changes associated with disease. Researchers can study biomarkers in blood, cerebrospinal fluid and brain imaging. #Alzheimers #Biomarkers #Research

Science moves quickly. Trust requires slowing down enough to ask: What do we know? What don't we know? What still needs to be proven? 🔬🧠 #Alzheimers #AlzheimersResearch #CaretoCure #EverythingALZ #dementia

🧠 Alzheimer’s is more than memory loss. Changes in language, reasoning, judgment, and everyday abilities can also be signs of disease. Understanding those changes matters. #Alzheimers #Dementia #BrainHealth #CaretoCure #Research

🔴 TODAY at 2 PM PT / 5 PM ET How do we know whether an Alzheimer’s treatment is working? And are our clinical trials measuring the changes that matter most? Join Dr. John Harrison for: 💥Alzheimer’s Trials: Are we really measuring what matters? tinyurl.com/ETSept29

Tomorrow: #AlzheimersTrials: Are we really measuring what matters? Join Dr. John Harrison of Metis Cognition Ltd. and #EverythingALZ for a conversation about measuring cognitive change and evaluating treatment outcomes. 2 PM PT / 5 PM ET Register: tinyurl.com/ETSept29